We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+12.46%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.24%
AUM
$17B
AUM Growth
+$1.34B
(+8.6%)
Cap. Flow
-$377M
Cap. Flow
% of AUM
-2.22%
Top 10 Holdings %
Top 10 Hldgs %
15.59%
Holding
389
New
43
Increased
82
Reduced
143
Closed
65
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$204M |
| 2 |
AbbVie
ABBV
|
+$141M |
| 3 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$130M |
| 4 |
Caterpillar
CAT
|
+$125M |
| 5 |
Johnson Controls International
JCI
|
+$90.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VPHM
VIROPHARMA INC
VPHM
|
+$188M |
| 2 |
Merck
MRK
|
+$155M |
| 3 |
Apple
AAPL
|
+$155M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$131M |
| 5 |
Bread Financial
BFH
|
+$96.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.01% |
| 2 | Industrials | 15.63% |
| 3 | Consumer Discretionary | 14.7% |
| 4 | Technology | 8.94% |
| 5 | Communication Services | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Bright Horizons
BFAM
$3.98B
| $20.8M | 0.12% |
565,300
-28,790
| -5% | -$1.03M |
|
|
MIC
202
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $20.7M | 0.12% |
380,490
+351,990
| +1,235% | +$19.1M |
|
|
CHMT
203
DELISTED
Chemtura Corporation
CHMT
| $20.7M | 0.12% |
+741,750
| New | +$18.6M |
|
204
Warner Bros
WBD
$64.7B
| $19.5M | 0.12% |
422,898
-196,835
| -32% | -$8.52M |
|
205
Cadence Design Systems
CDNS
$93.8B
| $19.4M | 0.11% |
1,382,761
+613,910
| +80% | +$8.23M |
|
206
Sensata Technologies
ST
$7.08B
| $19.3M | 0.11% |
497,455
+88,845
| +22% | +$3.4M |
|
207
QuidelOrtho
QDEL
$1.2B
| $19.2M | 0.11% |
621,676
-31,570
| -5% | -$810K |
|
208
Broadcom
AVGO
$1.99T
| $18.9M | 0.11% |
3,580,500
-9,020,300
| -72% | -$41.5M |
|
209
Matsons
MATX
$6.46B
| $18.8M | 0.11% |
718,227
-36,530
| -5% | -$940K |
|
210
MillerKnoll
MLKN
$1.66B
| $18.6M | 0.11% |
631,381
-31,800
| -5% | -$951K |
|
211
Celanese
CE
$4.96B
| $18.6M | 0.11% |
336,172
-18,345
| -5% | -$1.02M |
|
212
BGC Group
BGC
$5.25B
| $18.2M | 0.11% |
4,689,118
-236,376
| -5% | -$860K |
|
|
GENT
213
DELISTED
GENTIUM SPA ADS
GENT
| $18.2M | 0.11% |
318,074
-1,121,266
| -78% | -$49.8M |
|
|
VR
214
DELISTED
Validus Hold Ltd
VR
| $18.1M | 0.11% |
449,600
-154,380
| -26% | -$6.03M |
|
|
ESC
215
DELISTED
EMERITUS CORP
ESC
| $17M | 0.1% |
787,440
+14,520
| +2% | +$297K |
|
216
Albemarle
ALB
$14.2B
| $16.9M | 0.1% |
266,725
-9,100
| -3% | -$604K |
|
|
ULTI
217
DELISTED
Ultimate Software Group Inc
ULTI
| $16.6M | 0.1% |
108,179
-39,610
| -27% | -$5.99M |
|
|
WFT
218
DELISTED
Weatherford International plc
WFT
| $16.4M | 0.1% |
1,058,010
-31,670
| -3% | -$503K |
|
|
SNBR
219
DELISTED
Sleep Number
SNBR
| $16M | 0.09% |
759,580
+138,380
| +22% | +$2.9M |
|
220
Five Below
FIVE
$12.3B
| $15.8M | 0.09% |
365,669
+194,910
| +114% | +$9.34M |
|
|
ECHO
221
EchoStar
ECHO
$26.6B
| $15.4M | 0.09% |
382,810
-20,954
| -5% | -$819K |
|
|
KATE
222
DELISTED
Kate Spade & Company
KATE
| $14.1M | 0.08% |
+441,170
| New | +$13M |
|
|
SUNE
223
DELISTED
SUNEDISON, INC COM
SUNE
| $13.9M | 0.08% |
+1,068,830
| New | +$12.1M |
|
|
RKUS
224
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
| $13.7M | 0.08% |
963,970
+355,710
| +58% | +$5.23M |
|
|
EXAM
225
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
| $13.7M | 0.08% |
+457,202
| New | +$12.7M |
|
Similar funds
OAG
JG
CHP
SC
Westfield Capital Management's Q4 2013 Portfolio in Review
As of Q4 2013, Westfield Capital Management held 389 positions worth $17B, up 8.6% from $15.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Westfield Capital Management's Q4 2013 filing shows 43 new, 82 increased, 143 reduced and 65 closed positions. Its largest new stake was Teva Pharmaceuticals: 5,174,039 shares worth $207M. The largest sale was VIROPHARMA INC, an estimated $188M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.
- Westfield Capital Management's largest Q4 2013 buy was Teva Pharmaceuticals: 5,174,039 shares worth $207M.
- Westfield Capital Management added most to AbbVie in Q4 2013, an estimated $141M increase.
- Westfield Capital Management's biggest Q4 2013 reduction was VIROPHARMA INC, cutting an estimated $188M.
- Westfield Capital Management fully exited Citrix Systems Inc in Q4 2013, selling an estimated $131M.
- Westfield Capital Management's ten largest holdings make up 16% of its $17B portfolio in Q4 2013.
- Westfield Capital Management opened 43 new positions and closed 65 in Q4 2013.
- Westfield Capital Management's portfolio value rose 8.6% quarter-over-quarter to $17B.
Based on Westfield Capital Management's 13F filing for Q4 2013, filed 7 Feb 2014.